Table 1.
Studies reporting survival for PDAC and metachronous isolated lung metastases.
| Author | Year | Median age (years) | Sample size | Median Survival after recurrence (months) | Median overall survival (months) |
|---|---|---|---|---|---|
| Zheng et al.17 Meyers et al.18 Gotfried and Kozuch9 Kruger et al.19 Jones et al.6 Sahin et al.20 Liu et al.21 Guerra et al.13 * Wangjam et al.22 Watanabe et al.23 Nakagawa et al.24 ** Ariake et al.25 Liu et al.26 * Downs-Canner et al.12 |
2017 2014 2011 2016 2019 2018 2019 2020 2015 2017 2018 2017 2020 2016 |
67 68 53 69 66 66 62 NR NR 70 68 67 NR 66 |
24 15 3 27 52 47 22 286 24 11 22 25 79 49 |
20 14 36 31.3 15 15 NR NR 8.5 17 NR NR 83 NR |
36 32 NR 46.4 33 NR 11.8 34.7 27.8 36 NR 31.9 120 35.6 |
NR: Not Reported. *Metanalysis: data included are for PDAC and IPM after pancreatectomy.
**Study reported 5-year overall survival of about 50%.